Diagnosis, Differential ; Humans ; Infant ; Male ; Muscular Atrophy, Spinal ; diagnosis

Since Jaffe first described osteoid osteoma in 1935, it has become a well recognized clinical and pathological entity. The clinical picture is characteristic, the roentgenographic features are usually distinctive, and the pathological findings are unmistakable. Osteoid osteoma is curable by surgical excision. Often, however, a presumtive diagnosis and roentgenographic features, but surgical exploration fails to uncover the nidus. We reported a case of typical pathological specimen, roentgenographic picture and unusual clinical records with long duration and marked muscle atrophy which was hardly differentiated from herniated intervertebral disc or other spinal cord lesions.
Diagnosis ; Intervertebral Disc ; Muscular Atrophy ; Osteoma, Osteoid ; Spinal Cord

PURPOSE: The aim of this study was to describe the dynamic changes of the cervical dural sac and the spinal cord during neck flexion in patients suffering from Hirayama's disease and to present the usefulness of flexion MR study for the diagnosis. MATERIALS AND METHODS: Seven consecutive male patients (age ranging 17-43 years, mean age 23.7 years) with the clinical diagnosis of Hirayama's disease and 5 healthy subjects (aged 25-32 years) for controls had done cervical MRI from January 2001 through June 2002. Cervical MRI was done in neutral and neck flexed positions using 1.5 T system (Sonata, Siemens, Germany) and obtained images were reviewed by two radiologists. We compared the cervical MRI findings of 7 patients with those of 5 healthy controls regarding neck flexion induced changes in the lower cervical segments. RESULTS: Neutral positioned cervical sagittal MR images revealed subtle or mild cord atrophy in only 2 patients. On maximal neck flexion, AP diameter of the cresent posterior epidural space was increased and also cord flattening with anterior shifting of posterior wall of the lower cervical dural canal was noted in all 7 patients. In all 7 cases, the level and side of spinal cord changes corresponded to the clinical phenotype. All control subjects showed neither cord flattening nor widening of posterior epidural space on neck flexion. CONCLUSION: In patients with the clinical diagnosis of Hirayama's disease, MRI scans obtained on maximal neck flexion showed characteristically dynamic flattening of lower cervical cord and widening of posterior epidural space. Therefore, a flexion MR study is needed to prove the diagnosis.
Atrophy ; Diagnosis ; Epidural Space ; Humans ; Magnetic Resonance Imaging* ; Male ; Muscular Atrophy ; Muscular Atrophy, Spinal ; Neck ; Phenotype ; Spinal Cord ; Spinal Muscular Atrophies of Childhood* ; Upper Extremity*

Spinal muscular atrophy (SMA) is a neuromuscular disorder characterized by progressive anterior horn cell degeneration leading to motor weakness, muscular atrophy and denervation. Recently, the genes responsible for proximal muscular atrophy have been identified and named as survivor motor neuron (SMN) and neuronal apoptosis inhibitory protein genes. The clinical symptoms, courses and evaluation findings of proximal SMA type III are similar to those of distal SMA and proximal muscle myopathies such as limb gir-dle muscular dystrophy and fascioscapulohumeral muscular dystrophy. It cannot be diagnosed with muscle biopsy and electromyographic findings exclusively. In our case, the patient showed similar clinical manifestations of distal SMA. So we couldn't diagnose this case as SMA type III until we detected SMN 1 gene deletion. This case could be a good model for diagnostic approach to SMA type III and differential diagnosis to similar diseases.
Anterior Horn Cells ; Atrophy ; Biopsy ; Denervation ; Diagnosis, Differential ; Extremities ; Gene Deletion ; Humans ; Motor Neuron Disease ; Motor Neurons ; Muscle Weakness ; Muscular Atrophy ; Muscular Atrophy, Spinal* ; Muscular Diseases ; Muscular Dystrophies ; Neuronal Apoptosis-Inhibitory Protein ; Survivors

Child ; Humans ; Muscular Atrophy, Spinal ; blood ; diagnosis ; Polymerase Chain Reaction ; methods

We present two cases of the patients with spinal muscular atrophy(SMA) confirmed by molecular genetic studies. The first one is 1-year-old female child with SMA type II(Dubowitz disease) who visited pediatric outpatient for developmental delay. She presented lower extremity hypotonia which progress to upper extremities and inability to sit alone. Spinal cord MRI showed normal findings but the needle electromyography suggested the possibility of myopathy. Following muscle biopsy findings were consistent with spinal muscular atrophy and PCR-SSCP(polymerase chain reaction-single strand conformation polymorphism) analysis showed homozygous deletion of telomeric SMN(survivor motor neuron) exon 7. The second is a 19-year-old female with SMA type III(Kugelberg-Welander disease) who visited neurologic outpatient for limbs weakness. She presented slowly progressive gait disturbance without muscle atrophy. The significantly decreased motor power of proximal limbs was observed. And findings of electromyography and muscle biopsy were consistent with spinal muscular atrophy. PCR-SSCP analysis revealed homozyous deletion of exon 7 of telomeric SMN and deletion of exon 8 of centromeric SMN gene. PCR analysis for NAIP(neuronal apoptosis inhibitory protein) exon 5 and 13 revealed no deletion in both cases. Molecular genetic analysis for SMN gene will be very useful for rapid diagnosis of spinal muscular atrophy.
Apoptosis ; Biopsy ; Child ; Diagnosis ; Electromyography ; Exons ; Extremities ; Female ; Gait ; Humans ; Lower Extremity ; Magnetic Resonance Imaging ; Molecular Biology* ; Muscle Hypotonia ; Muscular Atrophy ; Muscular Atrophy, Spinal ; Muscular Diseases ; Needles ; Outpatients ; Polymerase Chain Reaction ; Spinal Cord ; Upper Extremity ; Young Adult

Spinal muscular atrophy(SMA) is the second most common fatal disease of childhood with autosomal dominant mode of inheritance, and in its less severe form the third most common neuromuscular disease of childhood after Duchenne muscular dystrophy. The genetic defect was found to be on the long arm of chromosome 5(5q11.2-q13.3) where many genes and microsatellite markers were missing. One of the most important genes is the Survival Motor Neuron(SMN) gene which is homozygously missing in 90% of SMA patients. Another important gene, the Neuronal Apoptosis Inhibitory Protein(NAIP) gene was found to be defective in 67% of SMA type I patients. Studies so far suggest SMA occurs when the genes on the long arm of chromosome 5 are mutated or deleted. Recently our hospital encountered 2 SMA patients of type I and II respectively. These patients both had homozygously defective SMN genes but intact NAIP genes. We are reporting these cases with bibliographic review and discussion. Korean SMA patients presumably have defects in SMN genes similar to those found in European patients, although the siginificance of NAIP genes remains to be established. SMN gene defects can be easily diagnosed using PCR and restriction enzymes, and this method could be applied towards convenient prenatal diagnosis and towards screening for family members at risk.
Apoptosis ; Arm ; Chromosomes, Human, Pair 5 ; Diagnosis* ; Humans ; Mass Screening ; Microsatellite Repeats ; Muscular Atrophy, Spinal* ; Muscular Dystrophy, Duchenne ; Neuromuscular Diseases ; Neurons ; Polymerase Chain Reaction ; Prenatal Diagnosis ; Wills

Spinal muscular atrophy(SMA) is an autosomal recessive disease characterized by diffuse proximal and distal weakness due to the deletions of the survival motor neuron(SMN) genes localized on the chromosome 5(q11.2-q13.3). One hypothesis is that the cause of SMA is a pathologic continuation of a process of programmed cell death that is normal in are embryonic life. The SMN genes are supposed to arrest apoptosis(programmed cell death) of motor neuroblasts. SMA is traditionally considered as a pure lower motor neuron disorder, for which a current definitive diagnosis can be established by a molecular genetic testing. We report a case of a female infant with severe hypotonia and frequent aspiration at the age of four months. She was diagnosed as SMA by a genetic study, but the nerve conduction studies showed more extensive sensory involvement in this case other than other classical cases of spinal muscular atrophy. To our knowledge, this is the first report of SMA with sensory nerve involvement in Korea.
Cell Death ; Diagnosis ; Female ; Humans ; Infant ; Korea ; Molecular Biology ; Motor Neurons ; Muscle Hypotonia ; Muscular Atrophy, Spinal* ; Neural Conduction

The objective of this study was to review the clinical characteristics of patients with spinal muscular atrophy and to emphasize the importance of performing genetic mutational analysis at initial patient assessment. This is a single center oriented, retrospective, and descriptive study conducted in Seoul, South Korea. Genetic mutational analysis to detect the deletion of exon 7 of the SMN1 gene on chromosome 5q13 was performed by multiplex ligation-dependent probe amplification. Clinical features, electrodiagnostic study results, muscle biopsy results, and laboratory test results were reviewed from patient medical records. Of all 28 patients (15 males and 13 females), all showed bilateral symmetric proximal dominant weakness. Among them, 3 patients were classified as type I, 14 patients as type II, and 11 patients as type III. Twenty-five patients had scoliosis and eight of these patients received surgical treatment for scoliosis with improvement in clinical outcomes. Ventilator support was used in 15 patients. In terms of the diagnostic process, 15 patients had completed an electrodiagnostic study and muscle biopsy before genetic testing, and six of these patients were initially misdiagnosed with myopathy. Owing to the similar clinical features of SMA and congenital myopathy, an electrodiagnostic study and muscle biopsy could create confusion in the correct diagnosis in some cases. Therefore, it is recommended that genetic mutation analysis should be conducted along with an electrodiagnostic study or muscle biopsy in the diagnostic process for spinal muscular atrophy.
Biopsy ; Diagnosis ; Exons ; Genetic Testing ; Humans ; Korea* ; Male ; Medical Records ; Multiplex Polymerase Chain Reaction ; Muscular Atrophy, Spinal* ; Muscular Diseases ; Retrospective Studies ; Scoliosis ; Seoul ; Ventilators, Mechanical

Spinal muscular atrophy (SMA) type I is a common severe autosomal recessive inherited neuromuscular disorder that has been mapped to chromosome 5q11.2-13.3. The survival motor neuron (SMN) gene, a candidate gene, is known to be deleted in 96% of patients with SMA type I. Presently, PCR and single strand conformation polymorphism (PCR-SSCP) analyses have been made possible for application to both archival slides and paraffin-embedded tissues. Archival materials represent valuable DNA resources for genetic diagnosis. We applied these methods for the identification of SMN gene of SMA type I in archival specimens for the prenatal diagnosis. In this study, we performed the prenatal diagnosis with chorionic villus sampling (CVS) cells on two women who had experienced neonatal death of SMA type I. DNA extraction was done from archival slide and tissue materials and PEP-PCR was performed using CVS cells. In order to identify common deletion region of SMN and neuronal apoptosis-inhibitory protein (NAIP) genes, cold PCR-SSCP and PCR-restriction site assay were carried out. Case 1 had deletions of the exons 7 and 8, and case 2 had exon 7 only on the telomeric SMN gene. Both cases were found to be normal on NAIP gene. These results were the same for both CVS and archival biopsied specimens. In both cases, the fetuses were, therefore, predicted to be at very high risk of being affected and the pregnancy were terminated. These data clearly demonstrate that archival slide and paraffin-embedded tissues can be a valuable source of DNA when the prenatal genetic diagnosis is needed in case any source for genetic analysis is not readily available due to previous death of the fetus or neonate.
Chorionic Villi Sampling ; Diagnosis ; DNA ; Exons ; Female ; Fetus ; Genes, vif ; Humans ; Infant, Newborn ; Motor Neurons ; Muscular Atrophy, Spinal* ; Neuronal Apoptosis-Inhibitory Protein ; Polymerase Chain Reaction ; Pregnancy ; Prenatal Diagnosis* ; Spinal Muscular Atrophies of Childhood*